Treatment of Acute Promyelocytic Leukemia (APL) With All-Trans Retinoic Acid, and Arsenic +/- Gemtuzumab.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Arsenic trioxide; Idarubicin; Methylprednisolone; Tretinoin
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 07 May 2019 Biomarkers information updated
- 09 Oct 2013 Planned end date changed from 1 Sep 2014 to 1 Sep 2015 as reported by ClinicalTrials.gov.
- 05 Apr 2012 Status changed from recruiting to active, no longer recruiting M.D. Anderson Cancer Center record.